SCM
ETON icon

Silverarc Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Silverarc Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,691
Closed -$115 – 92
2021
Q2 		$115 Buy
+18,691
New +$138K 0.05% 92

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Silverarc Capital Management's ETON Position: Q3 2021 in Review

Silverarc Capital Management sold out of Eton Pharmaceutcials (ETON) in Q3 2021, closing a stake of 18,691 shares — an estimated $115 sold.

Silverarc Capital Management first reported a position in ETON in Q2 2021 and held it in 1 quarter. The position peaked at $115 in Q2 2021. 37 funds tracked by Wall St. Rank hold ETON as of Q3 2021.

  • Silverarc Capital Management reported no remaining Eton Pharmaceutcials position as of Q3 2021 after selling out during the quarter.
  • Silverarc Capital Management sold 18,691 Eton Pharmaceutcials shares in Q3 2021, an estimated $115.
  • Silverarc Capital Management first reported a position in Eton Pharmaceutcials in Q2 2021 and held it in 1 quarter.
  • Silverarc Capital Management's Eton Pharmaceutcials position peaked at $115 in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2021.

Based on Silverarc Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.